Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)
Pharmaceutical Manufacturing • 
Queenstown, Central Region, Singapore • 51-100 Employees
Company overview
| Headquarters | 21 Biopolis Road, #04-24/28 Nucleos South Building,, Singapore, 138567, SG |
| Phone number | +6569246535 |
| Website | |
| NAICS | 3254 |
| Keywords | Clinical Trials, Biosimilars, Research And Development, Manufacturing, Pharmaceuticals, Antibody Therapeutics, Diagnostics, Vaccines, Cdmo, Pancreaticcancerdrug, Noveldrugs, Pauf, Pancreaticecancer |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
Key Contact at Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) Email Formats
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@prestigebio.com), used 94.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@prestigebio.com | 94.7% |
{first initial}{second initial}.{last name} | jo.doe@prestigebio.com | 2.6% |
{first name} | john@prestigebio.com | 2.6% |
About Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)
Prestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer. We are developing biosimilars to contribute on the patient's drug accessibility. Over 12 biosimilars we have been developing since 2015. And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device. The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) revenue & valuation
| Annual revenue | $8,469,945 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $27,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) has 38 employees across 9 departments.
Departments
Number of employees
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) Tech Stack
Discover the technologies and tools that power Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
Hosting
JavaScript libraries
Miscellaneous
Miscellaneous
JavaScript libraries
Australia
United Kingdom
United States
Frequently asked questions
4.8
40,000 users
